ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Sleep medicine · Sleep Med Rev · 2026-08-27

Network meta-analysis of 33 RCTs (5045 hospitalised patients): melatonin/melatonin receptor agonists (RR 0.77) and suvorexant (RR 0.51) were associated with lower delirium risk vs non-active control; midazolam showed no significant reduction (RR 1.64). Low–moderate certainty.

Meta-analysisn = 5,045
Chen et al. Sleep-modulating pharmacological interventions for delirium prevention: a systematic review and a network meta-analysis of randomized controlled trials
Gastroenterology · Endoscopy · 2026-07-21

ESGE/ESGENA guideline on sedation for GI endoscopy: recommends propofol first line (resource permitting), midazolam with opiates when analgesia is needed, a dedicated trained sedation provider, and risk-based pre-assessment and monitoring; mostly very low certainty evidence.

Guideline
Triantafyllou et al. Sedation for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) Guideline
Sleep medicine · J Clin Sleep Med · 2026-06-15

Meta-analysis of 22 studies (3478 OSA patients) of drug-induced sleep endoscopy: sedative type (propofol, dexmedetomidine or midazolam) was not associated with complete collapse rates; BIS monitoring was linked to less tongue base collapse and BMI to velum collapse.

Meta-analysisn = 3,478
Sung et al. Drug-induced sleep endoscopy in obstructive sleep apnea: a systematic review and meta-analysis of sedative agents, monitoring methods, and administration techniques

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.